Trial site
National Hospital Organization Sendai Medical Center
Sendai, 983-8520, JapanNot linked to an institution yet
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Completed3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- argenx3 trials
- Alfasigma S.p.A.1 trial
- Kagawa University1 trial
- Kiminori Kimura, MD1 trial
- and 2 more
Running trials
Recruiting
A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
NCT07681089· Phase 2· Kiminori Kimura, MD· Source
Contact: Junji Imamura, MD
Not yet recruiting
Breakthrough Platform Trial for PCAS
NCT07769086· Kagawa University· Source
Contact: Yu Kawazoe
Recruiting
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
NCT07673627· Phase 2· argenx· Source
Contact: Yasushi Suzuki, MD
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
NCT07294170· argenx· Source
Contact: Yasushi Suzuki, MD
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
NCT07284420· Phase 2· argenx· Source
Contact: Yasushi Suzuki, MD
Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
NCT06991257· Phase 2· Pfizer· Source
Recruiting
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT05730036· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Recruiting
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT05327114· Phase 2/3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05083169· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT04951622· Phase 3· Janssen Research & Development, LLC· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error